Goldman Sachs Sees Catalysts for Allergen (AGN) and Adds to Conviction Buy List
Tweet Send to a Friend
(Updated - May 13, 2016 8:58 AM EDT)Goldman Sachs upgraded Allergen (NYSE: AGN) from Buy to Conviction Buy, with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
